Skip to main content
Premium Trial:

Request an Annual Quote

GeneBio to Distribute Protagen Software Tool

NEW YORK (GenomeWeb News) – Geneva Bioinformatics will distribute Protagen’s Modiro, a software tool for rapid and automated detection of post-translational modifications in MS/MS datasets, the firms said in a joint statement today.
 
Under terms of the alliance, GeneBio will distribute the Modiro product on a global basis. The firms also intend to collaborate in linking the Modiro functionalities to GeneBio’s Pehnyx software platform for mass spectrometry data analysis.
 
“We are well aware of the reputation of both GeneBio and Phenyx within the industry and feel that our combined efforts will help to establish Modiro as the gold-standard for PTM analysis,” Christoph Hüls, CEO of Dortmund, Germany-based Protagen, said in a statement.
 
Further terms of the agreement were not disclosed.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.